CMS Delays Medicare GLP-1 Obesity Drug Coverage: BALANCE Model Postponed Beyond 2027
The Centers for Medicare & Medicaid Services (CMS) has delayed the launch of its BALANCE model—a temporary program to expand Medicare coverage for GLP-1 receptor agonists in obesity treatment—from January ... Read More